CLINICAL_TRIALS
trial_result
· 2011-09-12
Clinical Trial Update: A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows [Phase 3]
Summary
The document reports the completion of a Phase 3 long-term safety study of repeat PurTox treatments for glabellar rhytides.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mentor Worldwide, LLC | Conditions: Glabellar Rhytides | Phase 3 | Status: COMPLETED